IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
H57.00 covers a pupillary anomaly that is present when the documentation does not further classify it
Not intended for diagnosis, treatment, or prevention of any condition
They do not contain dosing, preparation, reconstitution or administration instructions, and they make no claim about what any compound would do for a person
By sticking to this treatment plan, doctors can manage Vitamin B12 deficiency well
KLOW is typically 80 mg total: 10 mg BPC-157, 10 mg TB-4, 10 mg KPV, 50 mg GHK-Cu